Pfizer, Moderna vaccines 94% effective in preventing hospitalization in adults 65 and older

2 min read Original article ↗

Add Axios as your preferred source to

see more of our stories on Google.

The patient is covid positive and has has a stroke. The patient is being flown from Providence St. Mary Medical Center to another hospital. (Francine Orr / Los Angeles Times via Getty Images)

A COVID-positive patient who suffered a stroke in December and was flown from Providence St. Mary Medical Center to another hospital. Photo: Francine Orr / Los Angeles Times via Getty Images

The Pfizer and Moderna vaccines were 94% effective in preventing hospitalization for COVID-19 among adults 65 years and older, according to a study by the Centers for Disease Control and Prevention.

Why it matters: The research, which studied 417 hospitalized adults in 14 states between January and March, adds real-world evidence from the clinical trials that vaccination protects against severe illness and hospitalization.

  • "These data suggest that continuing to rapidly vaccinate U.S. adults against COVID-19 will likely have a marked impact on COVID-19 hospitalization and might lead to commensurate reductions in post-COVID conditions and deaths," the report reads.

The state of play: Fully vaccinated individuals showed a 94% efficacy rate. Those who only had one dose had an effectiveness of 64%.

  • Older adults that contract COVID-19 are at a higher risk of getting severely ill, being hospitalized and dying, which is why it's important to increase vaccination efforts, the agency says.

Yes, but: The study also showed no significant vaccine effectiveness less than 14 days after the first dose of a vaccine, showing the importance of immunity build and continued use of social distancing measures and face coverings.